We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » New FDA Study Reveals Devicemakers Play Large Role in Delayed Reviews
New FDA Study Reveals Devicemakers Play Large Role in Delayed Reviews
July 22, 2011
A new FDA analysis of the total time it takes to review 510(k) submissions and the reasons for expanding review times in recent years show the primary drag is medical device sponsors taking longer and longer to respond adequately to the agency’s request for additional information (AI).